Suneel Ram is a spiritual seeker, sings in a band and was the subject of a comic novel two years ago about living with Duchenne muscular dystrophy, a rare genetic ...

Dupixent (dupilumab) is available in Japan in a 300 mg dose as a pre-filled syringe or pre-filled pen and is now available ...

Sanofi & Regeneron’s Dupixent receives Japanese marketing approval to treat patients with COPD: Paris Saturday, March 29, 2025, 09:00 Hrs [IST] The Ministry of Health, Labour an ...

The Ministry of Health, Labour and Welfare in Japan has granted marketing and manufacturing authorization for Dupixent (dupilumab) for the treatment of chronic obstructive pulmonary disease (COPD) in ...

Dupixent approved as the first-ever biologic medicine in Japan for patients with COPD Following recent approvals in the EU, China, and the US, this approval was based on pivotal phase 3 results in adu ...

Results from BOREAS and the replicate NOTUS Phase 3 trial were published in The New England Journal of Medicine. In addition to COPD ... Symptoms include persistent cough, excessive mucus production ...

Cold season is wrapping up as spring arrives, set to last until March or April, according to Johns Hopkins Medicine. A common cold is an infection of the nose and ... Symptoms of COVID-19 include ...

Silent reflux is a condition in which stomach acid flows back into the esophagus and irritates the throat. Dietary and lifestyle changes, including eating smaller meals, may relieve symptoms ...

Some studies suggest that honey helps to relieve symptoms of upper respiratory tract infections, such as cough or sore throat. Honey may even slow the spread of antimicrobial resistance. Heat: Cons: ...

For centuries, women faced seemingly insurmountable barriers to entering medicine and science, and were relegated to roles as caregivers rather than recognized as physicians and surgeons.

In a significant advancement for Nigeria’s healthcare sector, the Lagos State government has officially commissioned the O-Care Disposable Syringe Factory, Nigeria’s first facility dedicated ...